In The News

Ropes & Gray Advises TransMedics Group in Acquiring Organ Support and Heart Preservation Transport System Assets from Bridge to Life

Practices: Life Sciences Licensing, Collaborations & Joint Ventures, Mergers & Acquisitions, Intellectual Property, Intellectual Property Transactions, IP Structuring in M&A, Spinouts & Reorganizations, FDA Regulatory, Health Care, Employment, Executive Compensation & Employee Benefits Industries: Healthcare & Life Sciences

Ropes & Gray advised TransMedics Group Inc., a medical technology company transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, in its acquisition from Bridge to Life Ltd., of assets and intellectual property related to the Ex-Vivo Organ Support System (EVOSS) and LifeCradle Heart Preservation Transport System technologies.

EVOSS is a warm perfusion technology designed for lung and heart transplantation and LifeCradle is a cold perfusion technology designed for heart transplantation. TransMedics plans to further develop these innovative technologies and incorporate them into its next-generation OCS technology platform as it expands its product offerings and indications for organ transplantation. The transaction was announced on August 2. Financial terms were not disclosed.

The Ropes & Gray team was led by mergers & acquisitions partner Tara Fisher and IP transactions partner Hannah England and included employment & benefits partner Kyle Higley, tax partner David Saltzman, IP transactions partner Melissa Rones, health care partner Eve Brunts and life sciences regulatory & compliance partner Kellie Combs.

Cookie Settings